RNS Number : 4315E
Primary Health Properties PLC
26 February 2024
 

 

Primary Health Properties PLC

 

Director shareholding

 

The Company has been advised that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

 

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Harry Hyman

 

2

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Purchase by ISA in dividend re-investment plan

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.907

3,543

(d)

Aggregated information

Aggregated volume price

Single transaction

£3,214.04

 

(e)

Date of transaction

23 February 2024

 

(f)

Place of transaction

London Stock Exchange (xlon)

 

 

For further information:

Primary Health Properties PLC

Toby Newman, Company Secretary

+44(0) 7729 047 959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNOWRSNUUURR